Fragmin 2'500 I.E./0.2 mL, injection solution

( ARTG ) Prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (DVT). Extended treatment of symptomatic venous thromboembolism (VTE) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of VTE in patients with solid tumour cancers. Treatment of unstable coronary artery disease, i.e. unstable angina and non-ST-elevation myocardial infarction (also known as non-Q-wave myocardial infarction). Prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.